Private Placement

A former Navy SEAL's tech startup marks one year of using AI to help veterans navigate the VA claims maze for free, taking on predatory firms and red tape.

As AI moves from hype to enterprise reality, data integrity becomes critical. Ataccama's record Q4 growth reveals a new market imperative: data trust.

John Gaeta's Escape.ai partners with Play.Works to bring AI-driven short films to Roku and Fire TV, targeting a new generation of viewers.

Following a new White House mandate, Voyager Technologies is building the core infrastructure for a permanent lunar base, blending commerce and national security.

Estrella Immunopharma unveils promising Phase 1 data for its next-gen T-cell therapy, but can it overcome a crowded market and its own financial hurdles?

Cyber threat intelligence firm Intel 471 elevates CINO Michael DeBolt to President, signaling a strategy to embed deep operational expertise into its core.

Current blood thinners carry a risky trade-off. A new class of drugs targeting Factor XIa could prevent deadly clots without the dangerous bleeding.

Novo Nordisk exec Karin Conde-Knape joins Valo as CSO, signaling a major validation for AI's role in creating next-generation medicines.

The Trump Administration has unveiled a $12 billion strategic mineral stockpile to break reliance on China and secure the future of American manufacturing.

A new binational challenge offers $70,000 in funding, calling on students and entrepreneurs to build the next wave of water technology solutions.

Osisko Development hires a regulatory powerhouse, signaling a strategic push to de-risk its path to gold production amid rising environmental scrutiny.

Palomar Holdings finalizes its Gray Surety acquisition, backed by a new $450M credit facility, in a bold strategic move to challenge specialty insurance leaders.

As Mark Adams retires, Penguin Solutions appoints Kash Shaikh, a proven AI and SaaS leader, to accelerate its push into the booming enterprise AI market.

As Canada observes the 30th anniversary of Black History Month, a look at its origins, the icons it honours, and its vision for the future.

From AI brains to spider silk armor, the 'Ironman Economy' is more than a metaphor. But who are the real players and what is the actual investment case?

A looming federal tax credit deadline threatens solar projects. NuGen Capital's strategic investment aims to save distressed assets and stabilize the grid.

The firm's major investment in VA and NC blends value-add buys with new builds, navigating complex local markets to chase regional growth.

vTv Therapeutics shores up its finances with a deal worth up to $135M, sharpening its focus on a breakthrough Type 1 diabetes drug, cadisegliatin.

Ensem Therapeutics expands its global trial for ETX-636, a next-gen cancer drug designed to avoid common toxicities, into China's vast patient market.

With a major Phase 3 trial now in Europe, Crystalys Therapeutics aims to fill a critical gap in gout care with a drug already proven in Asian markets.